End to End Service Tailored to Your Needs

Project Experience

Therapeutics

We support clients in conducting Phase I-IV studies,
Investigator Initiated Studies, across various therapeutic
areas, including biologics, small molecules, bridging studies, and vaccines

Medical Device

We help conduct pilot, pivotal, and post-market surveillance
studies for medical devices in various therapeutic areas.

Bioequivalence and
Bioavailability Studies

Helps sponsors enter local market by managing and
implementing bioequivalence & bioavailability studies.

Non-interventional Studies

Gain real-world insights into therapies, understand
disease occurrence, identify risk factors, and monitor
long-term effectiveness across various therapeutic areas

Epidemiological Studies

Support clients in conducting epidemiological studies to
understand disease patterns, identify risk factors, and inform
public health strategies

Post-marketing Surveillance

Monitors safety, efficacy, and long-term outcomes after drug approval

Proven
Regulatory
Experience

100% Approval rate from
all clinical trials submitted

75 days average submission
to approval timeline

1 week or less submission
to regulatory bodies

PPR has experience with Phase I to Phase IV clinical trials and other non interventional studies on different therapeutic areas

Vaccines/Anti-infectives

Infectious Disease

Gastroenterology

Dermatology

 

 

PPR’s Strengths

End-to-end Service with extensive experience in regulatory affairs, project management, and post-trial activities including registration and marketing

Access to Pool of Experts including qualified investigators with good reputation and performance in their field

Experienced and versed in Conducting Trials including Common and Rare Diseases including Phase I to Phase IV studies and non interventional studies

Industry Leading Study Start Up Timelines

  • Document Preparation
  • Site Qualification Visits
  • Submission Preparation
  • This maybe shortened depending on the complexity of the trial
  • FDA, Ethics Committee/s Submission
  • Contract & Budget Negotiations
  • Preparation for Site Activation
  • Study Drug Importation
  • Study Drug Receipt on the Site
  • Site Initiation Visits
  • Screening & Enrollment of Patients
  • From Study Preparation to Patient Recruitment: 12-18 weeks
  • All efforts will be made to make all activities in parallel and to push timelines faster

News & Events

Pharma Peak Research to Showcase Philippine CRO Expertise at World Vaccine Congress 2025

Mar 31, 2025

Read More

Pharma Peak Research Emerges, Set to Accelerate Biopharmaceutical Development in the Philippines

May 11, 2022

Read More

How can we help you?